Xiangxiang Wu
156 Jinshui East Road
Zhengzhou, 450046, China
Zhengzhou, 450046, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Smart-responsive lentinan-DMXAA conjugate for synergistic STING-mediated pancreatic cancer immunotherapy.
Journal: International journal of pharmaceutics
Published: February 04, 2026
Intranasal triptolide in mice: a strategy to reduce neuroinflammation and boost cognitive function.
Journal: Immunopharmacology and immunotoxicology
Published: December 29, 2025
Inflammation-targeted nanoaggregates encapsulated triptolide and hyperoside for M2 macrophage repolarization and oxidative stress reversal in rheumatoid arthritis therapy.
Journal: Colloids and surfaces. B, Biointerfaces
Published: November 09, 2025
Total flavonoids of Prunella vulgaris exert anti-hepatocellular carcinoma effects through autophagy suppression mediated by activation of the PI3K/AKT/mTOR pathway.
Journal: Journal of ethnopharmacology
Published: August 29, 2025
A charge reversal nanomedicine based on dual pH-responsive crosslinked dextran-based polysaccharide for synergistic cancer chemo/chemodynamic therapy.
Journal: International journal of biological macromolecules
Published: May 13, 2025
Self-assembled triptolide prodrug nanovesicles loading with ginsenoside Rg3 for double-targeted therapy of pancreatic cancer.
Journal: Materials today. Bio
Published: April 13, 2025
PEGylated retinoate prodrug self-assembled nanomicelles loaded with triptolide for targeting treatment of rheumatoid arthritis and side effect attenuation.
Journal: Colloids and surfaces. B, Biointerfaces
Published: January 28, 2025
Research Progress of Liver Cancer Recurrence Based on Energy Metabolism of Liver Cancer Stem Cells.
Journal: Journal of hepatocellular carcinoma
Published: October 12, 2024
Progress in the Study of Intratumoral Microorganisms in Hepatocellular Carcinoma.
Journal: Journal of hepatocellular carcinoma
Published: September 19, 2024
Combination therapy using Cel-CSO/Taxol NPs for reversing drug resistance in breast cancer through inhibiting PI3K/AKT/NF-κB/HIF-1α pathway.
Journal: Drug delivery and translational research
Published: June 13, 2024
Cel-CS1K: A Celastrol-Chitosan Conjugate for Treating Diet-Induced Obesity.
Journal: Chemical research in toxicology
Published: May 21, 2024
Last Updated: 09/26/2026